Intelligent Bio Solutions Files 8-K
Ticker: INBS · Form: 8-K · Filed: Dec 18, 2024 · CIK: 1725430
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Intelligent Bio Solutions filed an 8-K on Dec 18, 2024, with Reg FD disclosures and financials.
AI Summary
Intelligent Bio Solutions Inc. filed an 8-K on December 18, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as GBS Inc., is incorporated in Delaware and headquartered in New York City.
Why It Matters
This filing indicates the company is providing updated disclosures and financial information to the SEC, which could be relevant for investors monitoring its financial health and regulatory compliance.
Risk Assessment
Risk Level: low — This is a routine filing of financial statements and disclosures, not indicating any immediate adverse events.
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Registrant
- GBS Inc. (company) — Former company name
- Glucose Biosensor Systems (Greater China) Holdings, Inc. (company) — Former company name
- December 18, 2024 (date) — Date of earliest event reported
FAQ
What specific information is being disclosed under Regulation FD?
The filing indicates a Regulation FD Disclosure, but the specific details of the disclosure are not provided in the provided text snippet.
What financial statements and exhibits are included in this filing?
The filing states that Financial Statements and Exhibits are included, but the content of these documents is not detailed in the provided text.
When was Intelligent Bio Solutions Inc. formerly known as GBS Inc.?
The date of the name change from GBS Inc. to Intelligent Bio Solutions Inc. was September 19, 2019.
What is the principal executive office address for Intelligent Bio Solutions Inc.?
The principal executive offices are located at 135 West 41st Street, 5th Floor, New York, NY 10036.
What is the fiscal year end for Intelligent Bio Solutions Inc.?
The fiscal year end for Intelligent Bio Solutions Inc. is June 30.
Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-12-18 17:15:17
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-050646.txt ( ) — 230KB
- inbs-20241218.xsd (EX-101.SCH) — 3KB
- inbs-20241218_lab.xml (EX-101.LAB) — 33KB
- inbs-20241218_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 18, 2024 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer